Annual Conference
Questors
Harm Reduction in Opioid Dependency Ibogaine & Psychedelic Medicine
Helping the Mental Health Industry Generate Tangible GrowthKRFI Global Health Initiative 2030 Conference brings market intelligence and business connections for the Private Public Sector Partnership for the Mental Health and current Endemic Opioid Use and Substance Use (OUD/SUD) Therapeutics industry.

We help companies expand their clinical impact, diagnostic influence, make data driven decisions through our industry intelligence, and link up with natural products psychedelic manufacturing pharmaceutical professionals to exchange knowledge and engage in quality networking.

At the core of KRFI, Ibogaine for Access for Benefit Sharing (ABS) is our mission to help natural products phytopharmaceutical businesses globally generate tangible growth. At the same time, our heart lies in giving back to society.

We empower the next generation by equipping underprivileged OUD/SUD patients with Harm reduction education with our analytical services for know your drugs app and campaigns.

December 6 & 7th 2022 l New York City

New York Academy of Medicine

Event Features                Co Sponsored Events

300+
Attendees
100
Organization
50
Expert Speakers
AGENDA AT A GLANCE
December 6th, Wednesday- Day 1

Plenary Session: 

Today’s Challenges and Opportunities in

Psychedelics and Ibogaine Medicine

Plenary Session: 

Global Health Clinical Trial Blockchain and

Current Healthcare Technologies.

Corporate Breakfast Keynote address (Sponsored event)

Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking

   Global Psychedelic and Ibogaine GMP manufacturing - Challenging the schedule Product


Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking - Coffee, Tea Break

   Advances in Psychedelics scheduled products natural products Development & Raw Material Transfer


Corporate Lunch Keynote address (Sponsored event)

Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking

   Psychedelics & Ibogaine Clinical Trial Cases Plan of Action


Plenary Session: The Next Big Steps for Psychedelics & Ibogaine GMP Manufacturing Success

   National Institute of Drug Abuse (NIDA)/CU Opioid Use Disorder Prevention center


Conference Day 1 VIRTUAL Working Group and Meeting

   VIRTUAL WORKING GROUP: The Next Big Steps for Psychedelics & Ibogaine Treatment Manual for Indications


Conference Day 1 Corporate Matching

Attending Network Cocktail 7-10 pm (Sponsored event)

   Post-Conference Site tour to Ibogaine, Cannabis, Psychedelic Companies for Pharma Manufacturing Facilities in US, EU, Canada (Ibogaine ABS for Central Africa and Nicaragua)


REGISTER NOW FOR 1-1 Attendee Networking and Company Visit

   Post-Conference Site tour to Big Pharma Manufacturing Manufacturing Facilities

Corporate Breakfast Keynote address (Sponsored event)

Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking

   Blockchain for Drug Supply Chain Security for Global Harm Reduction


Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking - Coffee, Tea Break

   Investment in Future Healthcare Technologies Clinical Trial Platform Blockchain


Corporate Lunch Keynote address (Sponsored event)

Exhibition Viewing & 1-1 Corporate Matching and Attendee Networking

   National Drug Research Product Analytics and Quality Control Diagnostics vs Harm Reduction Technology Panel 3D AI/VR/DB Platforms & Know-Drugs APP


Plenary Session: The Next Big Steps for Psychedelics & Ibogaine GMP Manufacturing Success

   Opportunities and Challenges in Regulatory Evaluation Panel


Conference Day 1 VIRTUAL Working Group and Meeting

  • VIRTUAL WORKING GROUP: Questors: Clinical Trial Management Platform Blockchain for PI, Universities, Hospitals, and NGOs
  • VIRTUAL WORKING GROUP: Drug Supply Chain Security Act for Global Drug Policy Coalition (1000 participant Petition launch)
Made on
Tilda